Schmidt, Benjamin Christopher; Sivanathan, Visvakanth; Schmiedel, Stefan et al.
The Ambulatory Management of COVID-19 Via the German Department of HealthDEUTSCHES ARZTEBLATT INTERNATIONAL. Bd. 117. H. 29-30. 2020 S. 507-508
Newsome, P.; Schattenberg, J.; Serfaty, L. et al.
THE ECONOMIC COST AND HEALTH BURDEN OF NON-ALCOHOLIC STEATOHEPATITIS IN THE EU5 COUNTRIESDIGESTIVE AND LIVER DISEASE. Bd. 52. 2020 S. S166-S167
Hardy, Timothy; Wonders, Kristy; Younes, Ramy et al.
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver diseaseCONTEMPORARY CLINICAL TRIALS. Bd. 98. 2020
Huber, Yvonne; Schattenberg, Joern M.
The new Focus on Metabolic Liver Diseases at UM Mainz is introducedGASTROENTEROLOGE. Bd. 15. H. 4. 2020 S. 343-345
Drenth, Joost P. H.; Schattenberg, Joern M.
The nonalcoholic steatohepatitis (NASH) drug development graveyard: established hurdles and planning for future successEXPERT OPINION ON INVESTIGATIONAL DRUGS. Bd. 29. H. 12. 2020 S. 1365-1375
Francque, Sven M.; Bedossa, Pierre; Ratziu, Vlad et al.
THE PANPPAR AGONIST LANIFIBRANOR INDUCES BOTH RESOLUTION OF NASH AND REGRESSION OF FIBROSIS AFTER 24 WEEKS OF TREATMENT IN NON-CIRRHOTIC NASH: RESULTS OF THE NATIVE PHASE 2b TRIALHEPATOLOGY. Bd. 72. 2020 S. 9A-11A
Dreher, M.; Wojnowski, L.; Tibyampansha, D. et al.
THE RHEUMA-VOR APP: OPTIMIZING THE EARLY DIAGNOSIS OF RHEUMATIC DISEASESANNALS OF THE RHEUMATIC DISEASES. Bd. 79. 2020 S. 1936-1936
Xu, Rui-hua; Arkenau, Hendrik-Tobias; Bang, Yung-Jue et al.
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line therapy in patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction (G/GEJ) adenocarcinomaJOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 4. 2020
Govaere, Olivier; Cockell, Simon; Tiniakos, Dina et al.
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosisSCIENCE TRANSLATIONAL MEDICINE. Bd. 12. H. 572. 2020
Heinrich, Sophia; Castven, Darko; Galle, Peter R. et al.
Translational Considerations to Improve Response and Overcome Therapy Resistance in Immunotherapy for Hepatocellular CarcinomaCANCERS. Bd. 12. H. 9. 2020